Home  »  Ipo Review  »  Valiant Laboratories Ipo

Let’s have a detailed review of the company and analytics of the Valiant Laboratories IPO release date, IPO offer price, subscription, Valiant Laboratories Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.

Face Value Rs 10
Price Band Rs 133 to Rs 140
Listing At BSE, NSE
Min. Order Quantity 105 Shares
Listing Date October 9, 2023
Offer for Sale Rs Million
Fresh Issue Rs 1524.6 Million
IPO Size Rs 1524.6 Million
Tick Size 1

Valiant Laboratories IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.

Live Performance – Valiant Laboratories Share Price

Valiant Laboratories IPO – Summary

Valiant Laboratories IPOThey are an Active Pharmaceutical Ingredient (“API”)/ Bulk Drug manufacturing company having a focus on manufacturing Paracetamol.

Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for manufacturing finished dosage forms or formulations. Paracetamol (Scientific name: Acetaminophen or para-hydroxy acetanilide -C8H9NO2), is one of the most commonly taken analgesics worldwide and is recommended as the first-line therapy in pain conditions.

The Promoter of this company is SHANTILAL SHIVJI VORA AND DHANVALLABH VENTURES LLP. The lead manager of the issue is UNISTONE CAPITAL PRIVATE LIMITED, and the Registrar of this issue is LINK INTIME INDIA PRIVATE LIMITED.

Check out Related IPO Links:

Valiant Laboratories IPO GMP
Valiant Laboratories IPO Allotment
LIVE Subscription – Valiant Laboratories IPO

Valiant Laboratories IPO Date

The opening and closing dates of Valiant Laboratories IPO are September 27, 2023 and October 3, 2023 respectively.

Valiant Laboratories IPO Subscription

Day / Date QIB NII RII Total Subscription
1st Day – 27th Sep 0.00x 0.10x 0.62x 0.33x
2nd Day –  28th Sep 0.05x 0.29x 1.29x 0.72x
3rd Day – 29th Sep 1.04x 1.52x 3.14x 2.19x
4th Day – 3rd Oct 20.83x 73.64x 16.06x 29.76x
Shares Offered or Net Issue 2,178,030 1,633,500 3,811,500 10,890,000

The shares subscribed by the public will be updated here.

Valiant Laboratories IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Allotment of Equity Shares are pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.

Valiant Laboratories Limited IPO Listing Date

Find the dates below on basis of allotment, refund, listing, and more:

Basis of Allotment Finalization October 5, 2023
Refunds Initiation October 6, 2023
Credit of Shares to Demat Account October 7, 2023
Share Listing Date October 9, 2023

Valiant Laboratories IPO Price Band

The face value of each share is Rs.10, but the price band of the IPO is Rs 133 to Rs 140

Valiant Laboratories IPO Equity Size

This Initial Public Issue of 10,890,000 Equity Shares of Rs.10 each for cash at a price of Rs 133 to Rs 140 per equity share aggregating to Rs.1524.6 Million.

Valiant Laboratories IPO Share Offering

Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of 10,890,000 Equity Shares of Rs.10/ each.

Issue Size: 10,890,000 Equity Shares of Rs.10 each, aggregating to Rs.1524.6 Million

Open Free Demat Account Now!

    Fill Your Details Here
    1. Open Demat AccountInvest in IPO

    Valiant Laboratories IPO – Live Performance

    The listing date of this IPO is October 9, 2023. You can check the live performance of the IPO here, only after it is listed on exchanges.

    Live IPO Performance – Valiant Laboratories Share Price

    Valiant Laboratories IPO Grey Market Premium

    The Valiant Laboratories Limited IPO Grey Market Premium price is Rs 25, the Kostak rate is Rs NA and the Subject to Sauda is Rs NA. 

    Valiant Laboratories IPO – Company Overview

    Paracetamol was initially approved by the U.S. Food and Drug Administration (“US FDA”) in 1951 and is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms.

    So, Paracetamol is often found combined with other drugs in many over-the-counter (“OTC”) allergy medications, cold medications, sleep medications, pain relievers, and other products.

    The pharmaceutical API industry in India is ranked third-largest globally in terms of volume, behind China and Italy –About 35 per cent of API and intermediaries produced in India are exported and the remaining API and intermediaries are sold in the domestic market, including captive consumption by several large formulation players.

    India is the largest provider of generic drugs, globally contributing to ~20% of global supply by volume of generic drugs.

    Valiant Laboratories IPO – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Million)
    31-Mar-23 Mar-22 31-Mar-21
    Total Assets 2127.58 1818.12 1063.14
    *Total Revenue 3387.72
    Total Expense
    Profit After Tax

    Earnings per Equity Share (in Million)

    31-Mar-23 Mar-22 31-Mar-21
    Basic & Diluted

    Further, their PAT for the period ended on March 31, 2023, March 31, 2022, and March 31, 2021, were Rs. 289.98 Million, Rs. 274.96 Million and Rs. 305.93 Million respectively.

    Valiant Laboratories IPO – Promoters

    The Promoter of this company is:


    List of Related Parties (Key Managerial Personnel)

    • Velji Karamshi Gogri, Chairman and Independent Director
    • Santosh Shantilal Vora, Managing Director
    • Shantilal Shivji Vora, Non-Executive & Non-Independent Director
    • Paresh Shashikant Shah, Executive Director
    • Sonal Amit Vira, Independent Director

    Valiant Laboratories IPO – Promoters Holding

    • Pre-Issue Share Holding – 100.00%
    • Post-Issue Share Holding – 74.94%

    Valiant Laboratories IPO Offer Details or Issue Details

     Particulars  No. Of Equity Shares
     Equity Shares Offered  Up to 10,890,000 Equity Shares aggregating up to Rs.1524.6 Million
    of which:
    Issue Reserved for the Market Makers Up to [●] Equity Shares aggregating up to Rs.[●]
    Net Issue to the Public Up to [●] Equity Shares aggregating up to Rs.[●]
    Of which:
    Retail Investors Portion Not less than [●] Equity Shares
    Other than Retail Individual Investors Not more than [●] Equity Shares
     Equity Shares outstanding prior to the Issue 32,560,000 Equity Shares
     Equity Shares outstanding after the Issue X Equity Shares

    Valiant Laboratories IPO Issue Object

    Their Company proposes to utilize the Net Proceeds towards funding the following objects:

    1. Investment in their wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (“VASPL”) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for speciality chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (“Proposed Facility”);
    2. Investment in VASPL for funding its working capital requirements; and
    3. General corporate purposes

    Valiant Laboratories IPO – Business Strategy

    • Diversification into new chemistries and industry
    • Increase in market share
    • Improve operational efficiencies through backward integration of the Proposed Facility
    • Increase their penetration into international markets including regulated markets

    Valiant Laboratories IPO – Basis of Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Experienced promoters and a strong management team.
    • Strong Focus on Sustainability in Operations.
    • Strategically located manufacturing facility.
    • Quality-Focused Compliant Manufacturing and R&D Infrastructure.
    • Reducing dependence on import of raw materials.

    The relevant quantitative factors are:

    Basic & Diluted EPS RONW (%) NAV (Rs.)
    28.86 30.86

    Valiant Laboratories IPO: Competitive Peers

    Face Value (Rs.) P/E EPS  (Rs.) Return on Net Worth (%) Revenue from operations (Rs. in Millions)
    Valiant Laboratories Limited 10 [●]
    Listed Peers
    Granules India Ltd 1
    Jagsonpal Pharmaceuticals Limited 1

    Valiant Laboratories IPO Lead Managers

    Lead Managers
    A/ 305, Dynasty Business Park,
    Andheri-Kurla Road, Andheri East,
    Mumbai –400 059, India.
    Telephone:+91 9820057533
    Email: mb@unistonecapital.com
    Investor grievance email: compliance@unistonecapital.com
    Contact Person:Brijesh Parekh
    Website: www.unistonecapital.com
    SEBI registration number: INM000012449
    CIN: U65999MH2019PTC330850

    Valiant Laboratories IPO Registrar to offer

    Registrar to the Offer
    C-101, 247 Park, 1st Floor
    L.B.S. Marg, Vikhroli West Mumbai 400 083, Maharashtra, India
    Telephone:+91 8108114949
    Facsimile:+91 2249186060Email: valiantlaboratories.ipo@linkintime.co.in
    Investor grievance email:valiantlaboratories.ipo@linkintime.co.in
    Contact Person: Shanti Gopalkrishnan
    Website: www.linkintime.co.in
    SEBI Registration Number: INR000004058
    CIN: U67190MH1999PTC118368

    Valiant Laboratories IPO – Other Details

    • Statutory Auditor – Raman S Shah & Co
    • Legal Counsel to the Company M/s. Alliance Law
    • Bankers to the Company –  Kotak Mahindra Bank Limited

    Valiant Laboratories IPO Review by Stock Brokers

    Top Stock Brokers Review Company Reputation Competitive Edge Financial Statement Popularity Index Promoters Reputation
    Angel Broking 7.5/10 7.4/10 8.5/10 8.1/10 7.1/10
    Sharekhan 7.2/10 7.1/10 8.6/10 8.1/10 7.2/10
    Kotak Securities 7.3/10 7.5/10 8.4/10 8.1/10 7.3/10
    ICICI Direct 7.3/10 7.3/10 8.7/10 8.1/10 7.1/10
    IIFL 7.5/10 7.2/10 8.8/10 8.0/10 7.1/10
    Edelweiss 7.5/10 7.4/10 8.4/10 8.3/10 7.2/10
    Zerodha 7.4/10 7.1/10 8.5/10 8.1/10 7.0/10
    5Paisa 7.1/10 7.1/10 8.4/10 8.1/10 7.1/10
    Karvy 7.4/10 7.3/10 8.2/10 8.1/10 7.1/10
    Motilal Oswal 7.1/10 7.1/10 8.6/10 8.3/10 7.2/10


    Subscribe to Valiant Laboratories IPO

      Fill Your Details Here
      1. Open Demat AccountInvest in IPO

      Valiant Laboratories Limited IPO News

      News 1 – IPO DRHP Download

      News 2 – IPO RHP Prospectus Download

      Valiant Laboratories IPO Review FAQs

      Check out various FAQs related to Valiant Laboratories IPO:

      What is the Issue Size of Valiant Laboratories IPO?

      The Company is making an initial public offer of 10,890,000 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.

      What is the Price band of Valiant Laboratories IPO?

      The price band for this particular IPO ranges between Rs 133 to Rs 140. As far as the face value of the share is concerned, it is Rs. 10 per share.

      What is the Valiant Laboratories IPO Open Date?

      The opening and closing dates for this IPO have been updated. The IPO is set to open on September 27, 2023, while the closing date is set at October 3, 2023.

      What is the Valiant Laboratories IPO Allotment Date?

      They also have the news regarding the respective allotment dates of this IPO. The basis of Allotment finalization is on October 5, 2023, refund initiation is on October 6, 2023, credit of shares is on October 7, 2023, and share listing date is on October 9, 2023.

      What is the Valiant Laboratories IPO Listing Date?

      Shares of this company shall be listed in the exchanges on October 9, 2023. The date, when the listing would be done, is stagnant on October 9, 2023.

      Who is the Registrar of Valiant Laboratories IPO?

      One of the reputed registrars is managing the issue of this IPO, i.e. LINK INTIME INDIA PRIVATE LIMITED. Their website will help you regarding the further information you are on the lookout for.

      Who is the Promoter of Valiant Laboratories IPO?

      Here are the promoters of this IPO – SHANTILAL SHIVJI VORA AND DHANVALLABH VENTURES LLP. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.

      What is the GMP of Valiant Laboratories IPO?

      They have obtained the GMP of this IPO and it is Rs 25. Further insights into the Kostak rate and subject to sauda or SS are as well included in this report.

      Is Valiant Laboratories IPO Good for Investment?

      They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.

      What is the PAT of Valiant Laboratories Company?

      They have the information on company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2023 in Million is 289.98, 2022 is 274.96, and 2021 is 305.93. 

      Calculate your return on investment!

      Asset Class ROI (Rs.) Profit (Rs.) Profit (%)
      Real Estate
      Fixed Deposit
      Mutual Fund

      Featured Topics


      Get 100% IPO Allotment Guarantee! Subscribe to IPO